Orphazyme Technical Analysis

<div class='circular--portrait' style='background:#FF9E01;color: white;font-size:4em;padding-top: 25px;;'>OR</div>
ORPHA -- Denmark Stock  

DKK 86.40  1.80  2.13%

As of the 31rd of March Orphazyme holds Risk Adjusted Performance of 0.3344, Coefficient Of Variation of 1127.11 and Semi Deviation of 6.65. Compared with Fundamental Indicators, Macroaxis technical analysis interface allows you to check existing technical drivers of Orphazyme as well as the relationship between them. Put it differently, you can use this information to find out if the company will indeed mirror its model of past market data or the prices will eventually revert. We found nineteen technical drivers for Orphazyme AS, which can be compared to its competitors. Please check Orphazyme AS Treynor Ratio as well as the relationship between Potential Upside and Expected Short fall to decide if Orphazyme AS is priced some-what accurately providing market reflects its current price of 86.4 per share.
View Technical Analysis For

Orphazyme AS Technical Analysis

The output start index for this execution was one with a total number of output elements of sixty. The True Range is a measure of Orphazyme AS volatility developed by Welles Wilder. View also all equity analysis or get more info about true range volatility indicators indicator.

Orphazyme AS Trend Analysis

Use this graph to draw trend lines for Orphazyme AS. You can use it to identify possible trend reversals for Orphazyme as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Orphazyme price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.

Orphazyme Best Fit Change Line

The following chart estimates an ordinary least squares regression model for Orphazyme AS applied against its price change over selected period. The best fit line has a slop of   0.024849  which means Orphazyme AS will continue generating value for investors. It has 122 observation points and a regression sum of squares at 23.35, which is the sum of squared deviations for the predicted Orphazyme price change compared to its average price change.

Orphazyme March 31, 2020 Technical Indicators

Please check Your Equity Center. Please also try Idea Breakdown module to analyze constituents of all macroaxis ideas. macroaxis investment ideas are predefined, sector-focused investing themes.
Company logos by clearbit
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page